Gene Therapy

I think that it's a good take-home message for our audience, clinical trial sounds easy and exciting, but as much as I know, a cost of a patient is about 10,000 dollars. So if you need the 1,000 patients, you're already closed with billion dollars and it's not an easy for a startup to do that. Depending on the size, it could start to become prohibitive for even some of these larger pharmaceutical companies. Yeah, that's a very good lesson for all of us. And my next question is related to what have you seen so far with your clinical studies? Have you seen any indication that indeed there are improvement in model organism or you met